News

Filter

Current filters:

Pfizer

76 to 85 of 97217 results

Spain’s Supreme Court opines on Pfizer dual pricing contracts

Spain’s Supreme Court opines on Pfizer dual pricing contracts

15-12-2014

The Spanish Supreme Court has reviewed a ruling adopted by the Audiencia Nacional, itself annulling a…

EuropeLegalPfizerPharmaceuticalPricingSpain

Novartis' Cosentyx demonstrates superiority to Stelara in head-to-head psoriasis study

Novartis' Cosentyx demonstrates superiority to Stelara in head-to-head psoriasis study

15-12-2014

Swiss drug major Novartis announced that the Phase IIIb CLEAR study for Cosentyx (secukinumab) met its…

CosentyxDermatologicalsNovartisPharmaceuticalResearchSwitzerland

Daiichi Sankyo launches new generic drugs

Daiichi Sankyo launches new generic drugs

15-12-2014

Japanese pharma major Daiichi Sankyo says its generics subsidiary, Daiichi Sankyo Espha, has launched…

Antibiotics and Infectious diseasesBlopressCardio-vascularCravitDaiichi SankyoElplatGenericsJapanMarkets & MarketingOncology

India’s National Pharmaceutical Pricing Authority caps price of 52 more drugs

India’s National Pharmaceutical Pricing Authority caps price of 52 more drugs

15-12-2014

The National Pharmaceutical Pricing Authority (NPPA) of India has issued a notice capping prices of 52…

BaxterGlaxoSmithKlineIndiaPharmaceuticalPricingRegulationWockhardt

NetScientific invests in PDS Biotechnology

NetScientific invests in PDS Biotechnology

15-12-2014

UK-based life sciences investor NetScientific has made an undisclosed investment in privately-held US…

Antibiotics and Infectious diseasesBiotechnologyMergers & AcquisitionsNetScientificOncologyPDS BiotechnologyUK

ETH and University of Zurich launch new translational center

ETH and University of Zurich launch new translational center

15-12-2014

Switzerland’s ETH Zurich and the University of Zurich (UZH) are taking their long-standing partnership…

ETH ZurichFinancialPharmaceuticalResearchSwitzerland

Australian mid-year economic and fiscal outlook does not show cost increases for PBS

Australian mid-year economic and fiscal outlook does not show cost increases for PBS

15-12-2014

The Mid-Year Economic and Fiscal Outlook released by the Australian government did not indicate any cost…

AustraliaHealthcare in AustraliaMedicines AustraliaPharmaceuticalRegulation

FDA approves third indication for Lilly’s Cyramza

FDA approves third indication for Lilly’s Cyramza

13-12-2014

The US Food and Drug Administration on Friday expanded the approved use of pharma major Eli Lilly’s…

CyramzaEli LillyOncologyPharmaceuticalRegulationUSA

76 to 85 of 97217 results

Back to top